About 23 results found for searched term "Proton Pump" (0.192 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1834 | Omeprazole (H 16868) | Proton Pump |
| H 16868; Omeprazol | ||
| Omeprazol is a first-in-class proton pump inhibitor (PPI) used in the treatment of dyspepsia, laryngopharyngeal reflux (LPR) and Zollinger–Ellison syndrome. | ||
| M2627 | Dexlansoprazole | Proton Pump |
| Dexlansoprazole, the dextrorotatory enantiomer of lansoprazole, is a proton pump inhibitor (PPI) formulated to have dual delayed-release properties. | ||
| M3056 | Tenatoprazole | Proton Pump |
| Tenatoprazole is a procompound of the proton pump inhibitor (PPI) class, which inhibits proton transport with IC50 of 3.2 μM. | ||
| M3137 | Zinc Pyrithione | Cuproptosis |
| Zinc Pyrithione is an anti-fungal and anti-bacterial drug that disrupts membrane transport by blocking proton pumps and is a potent copper ion carrier that can be used in copper death (cuproptosis) studies. | ||
| M3448 | Esomeprazole Sodium | Proton Pump |
| (S)-Omeprazole sodium | ||
| Esomeprazole Sodium is a sodium salt of esomeprazole that is a potent proton pump inhibitor with an IC50 of 0.076 mg/kg. | ||
| M3575 | Esomeprazole Magnesium | Proton Pump |
| Esomeprazole Magnesium is a proton pump inhibitor to reduce gastric acid secretion. | ||
| M3707 | Rabeprazole Sodium | Proton Pump |
| LY307640 sodium | ||
| Rabeprazole is a frequently used second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase. | ||
| M1583 | Omeprazole sulfone | Metabolite/Endogenous Metabolite |
| Omeprazole sulfone; Omeprazole sulphone | ||
| Omeprazole sulfone is a metabolite of Omeprazole, which is a proton pump inhibitor. | ||
| M5633 | Pantoprazole sodium | Proton Pump |
| SKF96022 sodium, BY-1023 sodium | ||
| Pantoprazole is a proton pump inhibitor drug that inhibits gastric acid secretion. It works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid. | ||
| M5728 | Lansoprazole | Proton Pump |
| A-65006, AG-1749 | ||
| Lansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. | ||
| M6194 | Esomeprazole Magnesium trihydrate | Autophagy |
| (S)-Omeprazole magnesium trihydrate | ||
| Esomeprazole Magnesium trihydrate is a proton pump inhibitor which reduces acid secretion through inhibition of the H+ / K+ ATPase in gastric parietal cells. | ||
| M14265 | Pantoprazole sodium hydrate | Proton Pump |
| BY1023 sodium hydrate; SKF96022 sodium hydrate | ||
| Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole sodium hydrate is also a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. | ||
| M20397 | Pantoprazole | Proton Pump |
| Pantoprazole is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. | ||
| M20434 | Rabeprazole | Proton Pump |
| Rabeprazole is an orally active proton pump inhibitor that inhibits gastric acid secretion by interacting with (H+/K+)-ATPase in gastric lining cells. In addition, Rabeprazole significantly inhibits the activity of Helicobacter pylori and may be used in studies related to various digestive disorders. | ||
| M20452 | Revaprazan Hydrochloride | Proton Pump |
| YH1885 | ||
| Revaprazan Hydrochloride is a new reversible proton pump inhibitor with long-lasting acid-suppressive effects. | ||
| M20496 | Ilaprazole sodium | Proton Pump |
| IY-81149 sodium | ||
| Ilaprazole sodium is the sodium salt form of ilaprazole, which is a proton pump inhibitor. | ||
| M20514 | Omeprazole Sodium | Proton Pump |
| Omeprazole Sodium is the sodium salt form of omeprazole, which is a proton pump inhibitor and suppresses gastric acid secretion. | ||
| M20547 | Rabeprazole Related Compound E | Proton Pump |
| Rabeprazole thioether; Rabeprazole Sulfide | ||
| Rabeprazole Related Compound E is the active metabolite of Rabeprazole and an orally active proton pump inhibitor that inhibits gastric acid secretion by interacting with (H+/K+)-ATPase in gastric lining cells. In addition, Rabeprazole Related Compound E significantly inhibits the activity of Helicobacter pylori and can be used in studies related to various digestive disorders. | ||
| M20570 | Ufiprazole | Others |
| Omeprazole sulfide | ||
| Ufiprazole (Omeprazole sulfide) is an intermediate used in the production of the gastric proton pump inhibitors omeprazole and esomeprazole. | ||
| M29007 | Abeprazan | Proton Pump |
| DWP14012; Fexuprazan | ||
| Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases. | ||
| M29008 | Abeprazan hydrochloride | Proton Pump |
| DWP14012 hydrochloride; Fexuprazan hydrochloride | ||
| Abeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan hydrochloride is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases. | ||
| M29058 | Vonoprazan hydrochloride | Proton Pump |
| TAK-438 hydrochloride | ||
| Vonoprazan hydrochloride, a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan hydrochloride inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. | ||
| M29085 | Revaprazan | Proton Pump |
| SB 641257 | ||
| Revaprazan (SB 641257) is a reversible proton pump inhibitor with significant anti-inflammatory effects. Revaprazan can be used for chronic gastric inflammation research. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
